Product NewsLab Informatics ClinPhone’s Drug Accountability Solution Wins International Best New Product Award
Product NewsLab Informatics ClinPhone Showcases its Complete Range of Clinical Technology Solutions at the DIA 43rd Annual Meeting
Product NewsLife Sciences TopoTarget Announces New Preclinical Results with Belinostat to be presented at AACR Annual Meeting
Product NewsSeparations Flexus DMPK Fully Automates Protein Precipitation Methods, Saving Time and Effort
Product NewsSeparations Wyatt Technology’s MALS instruments characterize novel malaria vaccine candidates
Product NewsLife Sciences Millipore and CXR Biosciences Announce New Drug Screening Platform Products
Product NewsLife Sciences Prestigious Academic Medical Center Licenses LabVantage’s Sapphire™ for its Research & Clinical Laboratory Operations
Product NewsLab Informatics ClinPhone Presents its Complete Range of Clinical Trial Software and Services at DIA Europe 2007
Product NewsDrug discovery > Clinical Development Argenta Discovery Announces the Initiation of a Phase 1 Clinical Trial with ADC4022 – A Potential New Therapy for Chronic Obstructive Pulmonary Disease (COPD) and Severe Asthma.
Product NewsDrug discovery > Lead Discovery TopoTarget’s new antidote for accidental tissue exposure during chemotherapy, Savene™, becomes 'gold standard'
Product NewsLife Sciences Bionas and PRIMACYT to cooperate on cell-based assay for prediction of hepatotoxic effects of drugs and chemicals
Product NewsLife Sciences ACE Biosciences and US Naval Medical research Center Collaborate to Progress World’s First Campylobacter Vaccine for Travellers’ Diarrhoea Through Phase II Trials
Product NewsLife Sciences ACE BioSciences’ Lead Product, The World’s First Commercial Vaccine For Travellers’ Diarrhoea Caused By Campylobacter, Enters Clinical Trials On Schedule
Product NewsDrug discovery > Clinical Development Avastin and Xeloda meet primary endpoints in large Phase III first line metastatic colorectal cancer study
Product NewsDrug discovery > Clinical Development Avastin et Xeloda remplissent les critères d'évaluation primaires d'une vaste étude de phase III sur le traitement de première ligne du cancer colo-rectal métastatique
Product NewsDrug discovery > Lead Discovery Collaboration entre Actelion et Roche dans le domaine des maladies auto-immunes
Product NewsDrug discovery > Clinical Development BioAlliance Pharma announces preliminary results of its Doxorubicin Transdrug® Phase I/II clinical trial for primary liver cancer
